The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway
Lung CancerPublished 22 September 2003
P. Murray
Citations85
SJR quartileQ1
SJR score1.75
SNIP1.22
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This pilot study demonstrates that the full study is feasible but would require the commitment and involvement of a large number of patients and physicians, and shows several advantages to investigations and diagnosis in the central arm, particularly in time to treatment initiation, patient satisfaction and rate of radical treatments.
Abstract
This pilot study demonstrates that the full study is feasible but would require the commitment and involvement of a large number of patients and physicians. The results show several advantages to investigations and diagnosis in the central arm, particularly in time to treatment initiation, patient satisfaction and rate of radical treatments. The improved rate of radical treatment could lead to an improved survival rate.
Keywords
Medicine
JNCI Journal of the National Cancer InstituteThe European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
15,964 Citations1993N.K. Aaronson, Sam H. Ahmedzai +17 more
The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
The LancetEarly Lung Cancer Action Project: overall design and findings from baseline screening
2,512 Citations1999Claudia I. Henschke, Dorothy I. McCauley +9 more
Low-dose CT can greatly improve the likelihood of detection of small non-calcified nodules, and thus of lung cancer at an earlier and potentially more curable stage, although false-positive CT results are common.
Journal of Occupational and Environmental MedicineLung Cancer Screening: The Mayo Program
538 Citations1986Robert S. Fontana, David Sanderson +4 more
Results of the randomized trial conducted at the Mayo Clinic showed that offering both procedures to high-risk outpatients every 4 months conferred no mortality advantage over standard medical practice that included recommended annual testing.
CHEST JournalScreening for Early Lung Cancer
538 Citations1984Myron R. Melamed, Betty J. Flehinger +4 more
The Memorial Sloan-Kettering lung cancer screening program was begun in 1974 to evaluate sputum cytology as a supplement to the annual chest x-ray examination for early detection and diagnosis, and it is suggested that the squamous carcinomas detected by cytologic examination alone are very slow growing and tend to remain localized until detectable by x-rays.
PubMedEarly lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study.
453 Citations1984Frost Jk, Ball Wc +8 more
Screening by sputum cytology was found to improve the detection only of squamous cell carcinoma, and screening by both roentgenography and cytology identified a greater proportion of the lung cancer cases at an earlier stage.
Journal of Clinical OncologyMitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
449 Citations1999M.H. Cullen, Lucinda Billingham +13 more
MIC chemotherapy prolongs survival in unresectable NSCLC without compromising QOL, and MIC CT improved survival in both trials (significantly in MIC2).
British Journal of CancerGemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
339 Citations2000H Anderson, Penelope Hopwood +12 more
Patients treated with gemcitabine + BSC reported better QL and reduced disease-related symptoms compared with those receiving BSC alone, and improvements in patient-assessed QL were significant in magnitude and were sustained.
British Journal of Diseases of the ChestThe natural history of lung cancer: A review based on rates of tumour growth
248 Citations1979D M Geddes
The considerable literature on tumour growth rates in lung cancer is used in an attempt to calculate the natural history of the disease and to assess the true value of existing treatments.
CHEST JournalCorrelation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung Cancer
214 Citations2000Edward F. Patz, Santiago E. Rossi +3 more
This study confirms stratifying patients with stage IA non-small cell lung cancer in the same TNM classification, given no apparent difference in survival, and caution that improved small nodule detection with screening CT may not significantly improve lung cancer mortality.
ThoraxBTS recommendations to respiratory physicians for organising the care of patients with lung cancer
160 Citations1998The Lung Cancer Working Party of The British Thoracic Society Standards of Care Committee
The British Thoracic Society recognises that it is of paramount importance to ensure that all patients with a working diagnosis of lung cancer have access to first class care and these recommendations will represent an important contribution to the delivery of better patient care and will be an essential contribution to other UK national initiatives.
ThoraxManagement and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study
132 Citations2001A. Gregor
This national population based study demonstrates low use of treatment, poor survival, and the influence of process of care on survival in patients with lung cancer in Scotland.
ThoraxDelays in the diagnosis and surgical treatment of lung cancer.
126 Citations1996J. Stephen Billing, Frank C. Wells
Patients admitted for resection of lung tumours frequently experience lengthy delays in diagnosis and preoperative investigations and these delays to definitive treatment appear unacceptable, according to this study.
Lung CancerDoes treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre
122 Citations2001Hakan Bozcuk, Craig Martin
Reducing patient delay, rather than reducing hospital delay alone, could be better strategies to improve NSCLC survival, as survival is dependent on classical prognosticators, but not on time from referral to treatment (hospital delay), expanding resources in oncology (equipment, drugs and personnel), and, perhaps, reducing patient delay.
ThoraxImproving surgical resection rate in lung cancer
114 Citations1998C Laroche, Frank C. Wells +6 more
Quick access investigation, high histological confirmation rates, routine CT scanning, and review of every patient with confirmed lung cancer by a thoracic surgeon led to a substantial increase in the successful surgical resection rate.
Lung CancerInfluence of delays on survival in the surgical treatment of bronchogenic carcinoma
102 Citations2002Federico González Aragoneses, Nicolás Moreno‐Mata +3 more
Whether the delay in time from when bronchogenic carcinoma is diagnosed until a therapeutic thoracotomy is performed affects patient survival is investigated to find no influence of delay upon the survival.
Journal of Thoracic and Cardiovascular SurgeryNational survey of the pattern of care for carcinoma of the lung
85 Citations1990Edward W. Humphrey, Charles R. Smart +5 more
An improvement in the overall 5-year survival when compared with Surveillance, Epidemiology, and End Results data was noted, whether this is a true improvement in survival or is the result of selection because of an unrecognized change in the pattern of care for patients with a carcinoma of the lung is unknown.
ThoraxManagement of lung cancer in South East Scotland.
64 Citations1996R J Fergusson, A. Gregor +2 more
A prospectively audit of the presentation, diagnosis, management, and outcome of patients presenting with lung cancer in South East Scotland confirms the importance of previously noted prognostic factors.
CHEST JournalCurrent Status of Surgical Resection for Lung Cancer
51 Citations1994F. Griffith Pearson
There have been no major breakthroughs in surgical management for primary lung cancer during the past 40 years, however, improved 5-year survival relates primarily to improved preoperative staging and appropriate selection of patients for resection.
British Journal of CancerTime trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86
46 Citations1990S.L. Watkin, GK Hayhurst +1 more
Data support the argument that with appropriate case selection, there is a survival benefit associated with active treatment for lung cancer, and the increasing use of combination chemotherapy would appear to have paralleled an increase in median and 2 year survival.
British Journal of CancerLung cancer -- management and outcome in Glasgow, 1991--92
32 Citations1998Eileen Kesson, Christine Bucknall +6 more
The lack of tumour staging or performance status data, the low proportion receiving chemotherapy or definitive surgery and the poor outcome after radical radiotherapy indicate the need for prospective audit and feedback of results.
Journal of Research in NursingDevelopment of nurse-led follow-up in the management of patients with lung cancer
21 Citations1999Sally Moore, Jessica Corner +1 more
The paper concludes that nurse-led follow-up care of lung cancer patients was demonstrated to be safe, acceptable and appropriately managed.
Hematology/Oncology Clinics of North AmericaNONSURGICAL MANAGEMENT OF NON-SMALL-CELL LUNG CANCER
6 Citations2001William T. Sause
No good clinical evidence to date suggests that including areas of subclinical involvement will result in higher cure rates, but combination therapy consisting of concurrent chemotherapy and irradiation seems to have yielded an improvement in short-term and median survival.
PubMed[Helical CT for lung-cancer screening: fourth report. Detectability of pulmonary lesions].
1 Citations1996Shigeki Itoh, Hiroko Satake +4 more
Since the detectability of HSCT was good for abnormal findings, showing increased attenuation in comparison with the lung parenchyma, it was considered to be a promising method for lung-cancer screening.